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	 Indole‐3‐acetic	 acid	 (1)	 on	 reaction	 with	 thionyl	 chloride,	 afforded	 2‐(1H‐indol‐3‐yl)acetyl
chloride	(2),	which	was	further	treated	with	aniline	and	various	substituted	anilines	through
base	 condensation	 reaction	 to	 obtain	 respected	 indole‐3‐acetic	 acid	 derivatives	 (3‐9).	 The
structures	of	all	new	compounds	were	elucidated	by	elemental	analysis,	Mass,	IR,	1H	NMR	and
13C	NMR	and	spectroscopic	techniques.	All	the	compounds	were	screened	for	their	antioxidant
activities	by	applying	in	vitro	methods	like	2,2‐diphenyl‐1‐picryl	hydrazyl	(DPPH)	free	radical
scavenging	 assay	 and	 inhibition	 of	 microsomal	 lipid	 peroxidation	 (LPO)	 assay.	 Butylated
hydroxy	anisole	 (BHA)	was	used	as	a	reference	antioxidant	 compound	and	 the	comparative
study	with	newly	synthesized	compounds	was	also	done.	Among	the	analogues,	compound	9
bearing	 electron	 donating	 methoxy	 substituent	 in	 addition	 to	 the	 phenolic	 moiety	 showed
predominant	 activity.	 It	 is	 conceivable	 from	 these	 studies	 that	 the	 coupling	 of	 aniline	 and
substituted	 anilines	 is	 the	most	 important	 feature	 for	 the	 significant	 antioxidant	 activity	 of
indole‐3‐acetic	acid	analogues	studied.	
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1.	Introduction	
	
There	 is	 abundant	 evidence	 that	 reactive	 oxygen	 and	
nitrogen	 species	 (ROS	 and	 RNS)	 are	 implicated	 in	 several	
physiological	 processes,	 such	 as	 in	 host	 defense	 against	
invading	 pathogens	 and	 signal	 transduction	 [1,2].	 An	
overproduction	 of	 such	 reactive	 species,	 however,	 plays	 a	
major	 role	 in	 several	 pathophysiological	 conditions,	 such	 as	
atherosclerosis,	 cardiovascular	 diseases,	 Parkinson	 and	
Alzheimer	 diseases,	 and	 some	 types	 of	 cancer	 [3‐7].	 To	
counterbalance	 such	 undesirable	 effects,	 the	 demand	 for	
natural	 and	 synthetic	 antioxidants	 to	 strengthen	 the	
endogenous	defenses	has	grown	in	recent	years.		
Antioxidants	 must	 react	 with	 radicals	 and	 other	 reactive	
species	 faster	 than	 biological	 substrates,	 thus	 protecting	
biological	 targets	 from	 oxidative	 damage	 [8,9].	 Furthermore,	
the	 resulting	antioxidant	radical	must	possess	a	high	stability,	
that	 is,	 the	 antioxidant	 radical	 must	 interrupt	 (rather	 than	
propagate)	a	chain	reaction	[10].	The	research	on	free	radicals	
provides	 theoretical	 information	 for	 the	 medicinal	
development	 and	 supplies	 some	 in	 vitro	 methods	 for	 quick‐
optimizing	 drugs;	 it	 attracts	 more	 scientific	 attention	 for	
bioorganic	 and	 medicinal	 chemists.	 In	 addition	 to	 the	
traditional	O‐H	bond	type	antioxidants,	aromatic	amines	having	
N‐H	 bond	 functions	 as	 the	 antioxidant	 have	 attracted	 much	
attention,	because	aromatic	amines	(Ar2NHs)	have	always	been	
the	central	structure	 in	many	currently	used	drugs	[11].	From	
the	 literature,	 phenolic	 compounds	 and	 some	 of	 the	 aromatic	
amines	(heterocyclic	amines)	showed	antioxidant	properties	in	
vitro	 and	 have	 been	 discussed	 from	 the	 view	 of	 chemical	
kinetics	[12,13].		
In	 the	 past	 decades	 research	 on	 synthesis	 and	 biological	
properties	of	indole‐3‐acetic	acid	has	been	actively	pursued	all	
over	 the	 world	 [14,15]	 and	 there	 is	 lot	 of	 scope	 and	 ample	
opportunity	 to	 look	 for	 new	 antioxidant	 molecules.	 Keeping	
this	 in	 our	mind,	 in	 the	 present	 investigation,	 we	 have	 taken	
one	of	 the	heterocyclic	aromatic	 compound	 i.e.	 indole‐3‐acetic	
acid	 as	 a	 model	 compound.	 Even	 though	 many	 biological	
studies	have	been	carried	out	on	indole‐3‐acetic	acid	analogues	
[16‐20],	the	antioxidant	activities	on	same	indole‐3‐acetic	acid	
analogues	 bearing	 substituted	 aniline	moieties	were	not	 been	
done.	
Recently,	 we	 have	 reported	 the	 antioxidant	 properties	 of	
5H‐dibenz[b,f]azepine,	 a	 tricyclic	 amine	 and	 some	 of	 its	
analogues,	 and	 their	 structure‐activity	 relationships	 was	
established	 based	 on	 the	 different	 substituent’s	 and	 positions	
[21‐23].	 Herein,	 we	 have	 reported	 the	 synthesis	 of	 indole‐3‐
acetic	 acid	 analogues	 obtained	 by	 coupling	 of	 aniline	 and	
different	 functionalized	 anilines.	 Antioxidant	 properties	 of	
indole‐3‐acetic	acid	and	its	analogues	were	evaluated	using	two	
well	 establishedwell‐established	 in	 vitro	 models	 like	 DPPH	
radical	 scavenging	 assay	 and	 Inhibition	 of	 microsomal	 lipid	
peroxidation	(LPO)	assay.	
	
2.	Experimental	
	
2.1.	Instrumentation	
	
Melting	points	were	determined	by	open	capillary	method	
and	were	uncorrected.	The	IR	spectra	were	recorded	on	a	FT‐
IR021	model	 in	 KBr	 disc.	 The	 1H	 and	 13C	 NMR	 spectra	 were	
recorded	on	Jeol	GSX	400	MHz	spectrophotometer	using	CDCl3	
as	 a	 solvent	 and	 the	 chemical	 shift	 (δ)	 are	 in	 ppm	 relative	 to	
internal	standard.	The	Mass	spectra	were	recorded	on	Waters‐
Q‐TOF	Ultima	spectrometer.	Elemental	analyses	were	obtained	
on	a	Carlo	Erba	analyzer.	
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Reagents:	(a)	KOH/	HCl,	250	oC;	(b)	SOCl2,	0	oC	
	
Scheme	1
	
	
2.2.	Chemicals	
	
DPPH	was	purchased	from	Sigma	Aldrich,	thionyl	chloride,	
ethyl	acetate,	n‐hexane,	tetrahydrofuron,	anhydrous	potassium	
carbonate,	methanol,	 chloroform,	 anhydrous	 sodium	sulphate,	
aniline	 and	 substituted	 aniline	 like	 2‐hydroxyaniline,																			
3‐hydroxyaniline,	 4‐hydroxyaniline,	 4‐hydroxy‐3nitroaniline,	
4‐bromo	 aniline,	 4‐hydroxy‐3‐methoxy	 aniline,	 were	 all	 of	
analytical	 grade	 and	 procured	 from	 Merck	 .	 TLC	 aluminium	
sheets,	silica‐gel60	F254	was	also	purchased	from	Merck.	
	
2.3.	Synthesis	
	
2.3.1.	Synthesis	of	2(1H‐indole‐	3‐yl)	acetyl	chloride	(2)	
	
To	the	well	stirred	solution	of	 indole‐3‐acetic	acid	(2	mM)	
in	 25	mL	 THF,	 thionyl	 chloride	 (2.2	mM)	 in	 25	mL	 THF	was	
added	 drop	 by	 drop	 for	 about	 15	 min.	 Then	 the	 reaction	
mixture	 was	 stirred	 at	 30	 oC	 temperature	 for	 about	 6	 hrs.	
Progress	 of	 the	 reaction	 was	 monitored	 by	 TLC	 using	 2:8	
methanol:chloroform	 mixture	 as	 mobile	 phase.	 Finally	 the	
reaction	mixture	was	concentrated	 in	rotary	evaporated	at	60	
oC,	 a	 brown	 solid	 product	 was	 obtained	 (Scheme	 1).	 Brown	
solid.	 Yield:	 84%.	 M.p.:	 115‐117	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 2913‐
3051	(Ar‐H),	3385	(NH),	1700	(C=O).	1H	NMR	(400	MHz,	CDCl3,	
δ):	7.0‐7.5	(m,	4H,	Ar‐H),	2.3‐2.5	(d,	2H,	CH2),	4.2	(s,	1H,	NH	of	
indole),	4.2	(d,	1H,	CH	of	indole).	13C	NMR	(100	MHz,	CDCl3,	δ):	
118.6	(1C,	Ar‐C),	119.9	(1C,	Ar‐C),	121.4	(1C,	Ar‐C),	111.4	(1C,	
Ar‐C),	 136.8	 (1C,	Ar‐C),	 127.1	 (1C,	Ar‐C),	 109.1	 (1C,	 Indole‐C),	
123.2	(1C,	indole	‐CH),	46.1	(1C,	CH2COCl),	172.8	(1C,	COCl).	MS	
(EI,	m/z(%):	193.10	(M+).	Anal.	Calcd.	for	C10H8ClNO:	C,	62.03;	
H,	4.16;	Cl,	18.31;	N,	7.23;	O,	8.26.	Found:	C,	62.00;	H,	4.15;	Cl,	
18.32;	N,	7.22.9;	O,	8.24	%.	
	
2.3.2.	General	procedure	 for	 the	synthesis	of	2‐(1H‐indol‐3‐
yl)	 acetyl	 chloride	 conjugated	 with	 different	 aniline	 and	
substituted	anilines	(3‐9)	
	
Aniline	 (1.2	mM)	 in	THF	 (25	mL)	 treated	with	 anhydrous	
K2CO3	 (100	mg).	 Later	 the	 solution	 of	 2(1H‐indole‐3‐yl)acetyl	
chloride	2	(1	mM)	in	THF	(25	mL)	was	added	drop	by	drop	for	
15	min	under	nitrogen	atmosphere.	The	reaction	mixture	was	
refluxed	 for	 6‐8	hr.	 The	progress	 of	 the	 reaction	mixture	was	
monitored	 by	 TLC	 using	 ethylacetate:hexane	 (6:4)	 as	 mobile	
phase.	 The	 reaction	mixture	was	 then	desolventized	 in	 rotary	
evaporator	 and	 the	 compound	was	 extracted	 in	 ethyl	 acetate.	
The	organic	layer	was	then	washed	with	water	and	dried	over	
anhydrous	 Na2SO4.	 The	 brown	 semisolid	 was	 obtained	 by	
further	 desolventation	 in	 rotary	 evaporator	 at	 70	 oC.	 Other	
respective	 indole‐3‐acetic	 acid	 analogues	 were	 obtained	 by	
conjugated	 with	 substituted	 anilines	 like	 2‐hydroxyaniline,							
3‐hydroxyaniline,	 4‐hydroxyaniline,	 4‐hydroxy‐3‐nitro	 aniline,	
4‐bromo	aniline,	4‐hydroxy‐3‐methoxy	aniline	by	following	the	
same	procedure.	The	analogues	were	separated	and	purified	by	
column	 chromatography	 by	 using	 mixture	 of	 ethyl	 acetate:	
hexane	60:40.	The	products	were	characterized	by	IR,	1H	NMR,	
13C	NMR	and	elemental	analysis	(Scheme	2).	
2‐(1H‐indol‐3‐yl)‐N‐phenylacetamide	 (3):	Brown	 semisolid.	
Yield:	87%.	FT‐IR	(KBr,	cm‐1):	3035‐2598	(Ar‐H),	3233	(NH	of	
indole),	1718	(C=O),	3376	(NH	of	aniline).	 1H	NMR	(400	MHz,	
CDCl3,	δ,	ppm):	7.0‐7.2	(m,	4H,	Ar‐H),	2.2‐2.6	(d,	2H,	CH2),	4.6	(s,	
1H,	NH	of	 indole),	3.8	(d,	1H,	 indole	CH),	9.7	(s,	1H,	N‐H);	6.8‐
7.3	(m,	5H,	Ar‐H	of	aniline).	13C	NMR	(100	MHz,	CDCl3,	δ,	ppm):	
121.4	 (1C,	Ar‐C),	128.2	 (1C,	Ar‐C),	 128.4	 (1C	Ar‐C),	128.5	 (1C,	
Ar‐C),	 121.3	 (1C,	 Ar‐C),	 138.2	 (1C,	 Ar‐C),	 168.8	 (1C,	CO),	 33.9	
(1C,	 NHCOCH2),	 109.4	 (1C,	 Indole‐C),	 123.2	 (1C,	 Indole‐C),	
127.1	(1C,	Indole‐C),	118.9	(1C,	Indole‐C),	119.5	(1C,	Indole‐C),	
121.5	(1C,	Indole‐C),	111.0	(1C,	Indole‐C),	136.4	(1C,	Indole‐C).	
MS	 (EI,	 m/z(%):	 250.21	 (M+).	 Anal.	 Calcd.	 for	 C16H14N2O:	 C,	
76.78;	 H,	 5.64;	 N,	 11.19;	 O,	 6.39.	 Found:	 C,	 76.76;	 H,	 5.62;	 N,	
11.18;	O,	6.37%.	
N‐(2‐hydroxyphenyl)‐2‐(1H‐indol‐3‐yl)acetamide	(4):	Brown	
semisolid.	 Yield:	 83%.	 FT‐IR	 (KBr,	 cm‐1):	 2827‐3049	 (Ar‐H),	
3210	 (NH	 of	 indole),	 3296‐3364	 (phenolic‐OH),	 1710	 (C=O),	
3375	(NH	of	substituted	aniline).	 1H	NMR	(400	MHz,	CDCl3,	δ,	
ppm):	7.4‐7.0	(m,	4H,	Ar‐H),	2.3‐2.6	(d,	2H,	CH2),	4.4	(s,	1H,	NH	
of	 indole),	 3.9	 (d,	 1H,	 indole	 CH),	 9.4	 (s,	 1H,	 N‐H),10.1(s,	 1H,	
phenolic	 ‐OH	 of	 substituted	 aniline),	 6.7‐7.2	 (m,	 4H,	 Ar‐H	 of	
substituted	aniline).	 13C	NMR	(100	MHz,	CDCl3,	δ,	ppm):	126.2	
(1C,	Ar‐C),	148.5	(1C,	Ar‐C),	116.3	(1C,	Ar‐C),	125.8	(1C,	Ar‐C),	
121.8	 (1C,	Ar‐C),	 120.5	 (1C,	Ar‐C),	 33.7	 (1C,	NHCOCH2),	 168.6	
(1C,	CO),	118.5	(1C,	 Indole‐C),	119.7	(1C,	 Indole‐C),	121.9	(1C,	
Indole‐C),	111.1	(1C,	Indole‐C),	136.4	(1C	Indole‐C),	127.1	(1C,	
Indole‐C),	 109.1	 (1C,	 Indole‐C),	 123.3	 (1C,	 Indole‐C).	 MS	 (EI,	
m/z(%):	266.02	(M+).	Anal.	Calcd.	 for	C16H14N2O2:	C,	72.16;	H,	
5.30;	N,	10.52;	O,	12.02.	Found:	C,	72.14;	H,	5.28;	N,	10.51;	O,	
12.00%.	
N‐(3‐hydroxyphenyl)‐2‐(1H‐indol‐3‐yl)acetamide	(5):	Brown	
semisolid.	 Yield:	 81%.	 FT‐IR	 (KBr,	 cm‐1):	 3046‐2824	 (Ar‐H),	
3310	 (NH	 of	 indole),	 3201‐3360	 (phenolic	 ‐OH),	 1660	 (C=O),	
3200	(NH	of	substituted	aniline).	 1H	NMR	(400	MHz,	CDCl3,	δ,	
ppm):	7.3‐7.6	(m,	4H,	Ar‐H),	2.1‐2.5	(d,	2H,	CH2),	4.9	(s,	1H,	NH),	
4.0	(d,	1H,	indole	CH),	9.9	(s,	1H,	N‐H),	9.4	(s,	1H,	phenolic	‐OH	
of	 substituted	 aniline),	 6.7‐7.2	 (m,	 4H,	 Ar‐H	 of	 substituted	
aniline).	 13C	NMR	 (100	MHz,	 CDCl3,	 δ,	 ppm):	 139.7	 (1C,	 Ar‐C),	
105.4	(1C,	Ar‐C),	158.8	(1C,	Ar‐C),	114.8	(1C,	Ar‐C),	130.2	(1C,	
Ar‐C),	 109.5	 (1C,	 Ar‐C),	 33.5	 (1C,	 NHCOCH2),	 168.7	 (1C	 ,CO),	
118.5	(1C,	Indole‐C),	119.6	(1C,	Indole‐C),	121.5	(1C,	Indole‐C),	
111.0	(1C,	Indole‐C),	136.1	(1C,	Indole‐C),	127.2	(1C,	Indole‐C),	
109.5	 (1C,	 Indole‐C),	 123.2	 (1C,	 Indole‐C).	 MS	 (EI,	 m/z(%):	
266.12	 (M+).	 Anal.	 Calcd.	 for	C16H14N2O2:	 C,	 72.16;	H,	 5.30;	N,	
10.52;	O,	12.02.	Found:	C,	72.15;	H,	5.28;	N,	10.50;	O,	12.00%.	
N‐(4‐hydroxyphenyl)‐2‐(1H‐indol‐3‐yl)acetamide	(6):	Brown	
semisolid.	 Yield:	 84%.	 FT‐IR	 (KBr,	 cm‐1):	 3042‐2828	 (Ar‐H),	
3336	 (NH	 of	 indole),	 3210‐3360	 (phenolic	 OH),	 1701(C=O),	
3256	(NH	of	substituted	aniline).	 1H	NMR	(400	MHz,	CDCl3,	δ,	
ppm):	7.3‐7.0	(m,	4H,	Ar‐H),	2.4‐2.6	(d,	2H,	CH2,	4.8	(s,	1H,	NH),	
4.5	 (d,	 1H,	 indole	 CH),	 9.3	 (s,	 1H,	N‐H,),	 9.8	 (s,	 1H,	 phenolic	 ‐
OH),	6.9‐7.4	(m,	4H,	Ar‐H	of	substituted	aniline).	13C	NMR	(100	
MHz,	CDCl3,	δ,	ppm):	131.0	 (1C,	Ar‐C),	123.2	 (1C,	Ar‐C),	116.4	
(1C,	Ar‐C),	154.3	(1C,	Ar‐C),	116.3	(1C,	Ar‐C),	123.2	(1C,	Ar‐C),	
168.5	(1C,	CO),	33.2	(1C,	NHCOCH2),	118.6	(1C,	Indole‐	C),	119.6	
(1C,	Indole‐C),	121.5	(1C,	Indole‐C),	111.3	(1C,	Indole‐C),	136.7	
(1C,	Indole‐C),	127.3	(1C,	Indole‐C),	109.7	(1C,	Indole‐C),	123.4	
Naik	et	al.	/	European	Journal	of	Chemistry	2	(3)	(2011)	337‐341	 339	
 
 
 
	
	
Reagents:	(a)	THF,	anhydrous	K2CO3,	N2	atmosphere,	reflux.	
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(1C,	 Indole‐C).	MS	 (EI,	m/z(%)):	 266.14	 (M+).	Anal.	 Calcd.	 for	
C16H14N2O2:	 C,	 72.16;	 H,	 5.30;	 N,	 10.52;	 O,	 12.02.	 Found:	 C,	
72.14;	H,	5.29;	N,	10.51;	O,	12.00%.	
N‐(hydroxy‐3‐nitrophenyl)‐2‐(1H‐indol‐3‐yl)acetamide	 (7):	
Brown	 solid.	 Yield:	 84%.	M.p.:	 145‐147	 oC.	 FT‐IR	 (KBr,	 cm‐1):	
3048‐2828	 (Ar‐H),	 3260	 (NH	of	 indole),	 3200‐3396	 (phenolic	
OH),	 1690	 (C=O),	 3198	 (NH	 of	 substituted	 aniline).	 1H	 NMR	
(400	MHz,	CDCl3,	δ,	ppm):	7.2‐7.0	(m,	4H,	Ar‐H),	2.4‐2.6	(d,	2H,	
CH2),	4.5	(s,	1H,	NH),	3.7	(d,	1H,	 indole	CH),	9.12	(s,	1H,	N‐H,),	
10.1	(s,	1H,	phenolic	‐OH),	7.2‐7.9	(m,	3H,	Ar‐H	of	of	substituted	
aniline).	 13C	NMR	 (100	MHz,	CDCl3,	 δ,	 ppm):	 135.0	 (1C,	Ar‐C),	
148.4	(1C,	Ar‐C),	119.8	(1C,	Ar‐C),	112.7	(1C,	Ar‐C),	132.4	(1C,	
Ar‐C),	114.5(1C,	Ar‐C),	33.9	(1C,	NHCOCH2),	118.5	(1C,	 Indole‐
C),	119.9	(1C,	Indole‐C),	121.5	(1C,	Indole‐C),	111.1	(1C,	Indole‐
C),	136.7	(1C,	Indole‐C),	127.5	(1C,	Indole‐C),	109.2	(1C,	Indole‐
C),	 122.8	 (1C,	 Indole‐C).	MS	 (EI,	m/z(%)):	 311.01	 (M+).	 Anal.	
Calcd.	 for	 C16H13N3O:	 C,	 61.73;	 H,	 4.21;	 N,	 13.50;	 O,	 20.56.	
Found:	C,	61.71;	H,	4.20;	N,	13.52;	O,	20.55%.		
N‐(4‐bromophenyl)‐2‐(1H‐indol‐3‐yl)acetamide	 (8):	 Brown	
semisolid.	 Yield:	 89%.	 FT‐IR	 (KBr,	 cm‐1):	 3049‐2827	 (Ar‐H),	
1670(C=O),	 3312	 (NH	 of	 indole),	 3275	 (NH	 of	 substituted	
aniline).	1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	7.3‐7.9	(m,	4H,	Ar‐
H),	2.4‐2.6	 (d,	2H,	CH2),	4.7	 (s,	1H,	NH),	3.7	 (d,	1H,	 indole	CH)	
7.3‐7.7	 (m,	 4H,	 Ar‐H	 of	 bromoaniline),	 9.13	 (s,	 1H,	 N‐H,)	 13C	
NMR	(100	MHz,	CDCl3,	δ,	ppm):	133.1	(1C,	Ar‐C),	122.5	(1C,	Ar‐
C),	 114.1	 (1C,	 Ar‐C),	 152.1(1C,	 Ar‐C),	 118.4	 (1C,	 Ar‐C),	 122.5	
(1C,	 Ar‐C),	 33.1	 (1C,	 NHCOCH2),	 168.9	 (1C,	 CO),	 118.8	 (1C,	
Indole‐C),	119.7	(1C,	Indole‐C),	121.9	(1C,	Indole‐C),	1110	(1C,	
Indole‐C),	136.1	(1C,	Indole‐C),	127.1	(1C,	Indole‐C),	109.1	(1C,	
Indole‐C),	123.3	(1C,	 Indole‐C).	MS	(EI,	m/z(%)):	344.00	(M+).	
Anal.	 Calcd.	 for	 C16H13BrN2O:	 C,	 58.38;	 H,	 3.98;	 Br,	 24.27;	 N,	
8.51;	 O,	 4.86.	 Found:	 C,	 58.36;	 H,	 3.99;	 Br,	 24.25;	 N,	 8.50;	 O,	
4.85%.	
N‐(4‐hydroxy‐3‐methoxyphenyl)‐2‐(1H‐indol‐3‐yl)acetamide	
(9):	Brown	semisolid.	Yield:	87%.	FT‐IR	(KBr,	cm‐1):	3039‐2817	
(Ar‐H),	1699	(C=O),	3310	(NH	of	indole),	3210‐3300	(phenolic	
OH),	 3297	 (NH	 of	 substituted	 aniline).	 1H	 NMR	 (400	 MHz,	
CDCl3,	δ,	ppm):	7.4‐7.1	(m,	4H,	Ar‐H),	2.2‐2.6	(d,	2H,	CH2),	4.4	(s,	
1H,	 NH),	 3.9	 (d,	 1H,	 indole	 CH)	 9.4	 (s,	 1H,	 N‐H),	 11.2	 (s,	 1H,	
phenolic	 ‐OH	 ),	 3.8	 (s.3H,	 OCH3)	 ,6.8‐7.2	 (m,	 3H,	 Ar‐H	 of	
substituted	 aniline).	 13C	 NMR	 (100	MHz,	 CDCl3,	 δ,	 ppm):	 56.0	
(1C,	ArOHOCH3),	151.4	 (1C,	Ar‐C),	144.5	(1C,	Ar‐C),	117.5	 (1C,	
Ar‐C),	 115.8	 (1C,	 Ar‐C),	 132.5	 (1C,	ArC),	 106.2	 (1C,	ArC),	 33.7	
(1C,	 NHCOCH2),	 118.6	 (1C,	 Indole‐C),	 119.3	 (1C,	 Indole‐C),	
121.2	(1C,	Indole‐C),	111.0	(1C,	Indole‐C),	136.5	(1C,	Indole‐C),	
127.3	(1C,	Indole‐C),	109.0	(1C,	Indole‐C),	123.0	(1C,	Indole‐C).	
MS	 (EI,	 m/z(%):	 296.22	 (M+).	 Anal.	 Calcd.	 for	 C17H16N2O3:	 C,	
68.91;	 H,	 5.44;	 N,	 9.45;	 O,	 16.20.	 Found:	 C,	 68.90;	 H,	 5.45;	 N,	
9.46;	O,	16.18%.	
	
2.4.	Biological	evaluation	‐	antioxidant	activity	studies	
	
The	newly	synthesized	compounds	were	screened	for	their	
antioxidant	activities	using	a	stable	free	radical	DPPH	assay	and	
Inhibition	 of	 microsomal	 LPO	 assay.	 The	 compounds	 under	
study	were	 dissolved	 in	 distilled	 ethanol	 (50	mL)	 to	 prepare	
1000	µM	solution.	Solutions	of	different	concentrations	(10,	25,	
50,	100,	200	and	500	µM)	were	prepared	by	serial	dilution	and	
the	antioxidant	activity	was	studied.	
	
2.4.1.	Animals	
	
The	 antioxidant	 activity	 of	 the	 target	 compounds	1‐9	 and	
BHA	was	tested	on	adult	male	Wister	rats	weighing	450‐520	g.	
All	 animals	 were	 allowed	 free	 access	 to	 water	 and	 kept	 at	
constant	 diet.	 Totally	 10	 rats	 were	 used	 for	 the	 isolation	 of	
microsomes.	
	
2.4.2.	DPPH	free	radical	scavenging	activity	
	
The	 DPPH	 radical	 scavenging	 effect	 was	 carried	 out	
according	 to	 the	 method	 first	 employed	 by	 Blois	 [24].	
Compounds	 of	 different	 concentrations	 were	 prepared	 in	
distilled	 ethanol,	 1	 mL	 of	 each	 compound	 solutions	 having	
different	 concentrations	 (10,	 25,	 50,	 100,	 200	 and	 500	 µM)	
were	taken	in	different	tubes,	4	mL	of	0.1	mM	ethanol	solution	
of	 DPPH	 was	 added	 and	 shaken	 vigorously.	 The	 tubes	 were	
then	incubated	in	the	dark	room	at	room	temperature	(RT)	for	
20	min.	 A	DPPH	 blank	was	 prepared	without	 compound,	 and	
ethanol	 was	 used	 for	 the	 baseline	 correction.	 Changes	
(decreases)	in	the	absorbance	at	517	nm	were	measured	using	
a	UV‐Visible	Spectrophotometer	and	 the	remaining	DPPH	was	
calculated.	 The	 percent	 decrease	 in	 the	 absorbance	 was	
recorded	 for	 each	 concentration,	 and	 percent	 quenching	 of	
DPPH	was	calculated	on	the	basis	of	decrease	in	absorbance	of	
the	 radical.	 The	 radical	 scavenging	 activity	 was	 expressed	 as	
the	inhibition	percentage	and	was	calculated	using	the	formula;	
	
Radical	scavenging	activity	(%)	=	[(Ao	‐A1/	Ao)	x	100]	 (1)	
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where	 Ao	 is	 the	 absorbance	 of	 the	 control	 (blank,	 without	
compound)	 and	 A1	 is	 the	 absorbance	 of	 the	 compound.	 The	
radical	 scavenging	 activity	 of	 BHA	 was	 also	 measured	 and	
compared	with	that	of	the	newly	synthesized	compound.	
	
2.4.3.	Inhibition	of	microsomal	lipid	peroxidation	assay	
	
Liver	 excised	 from	 adult	 male	 Wister	 rats,	 was	
homogenized	 (20	 g/100	 mL	 Tris	 buffer)	 in	 0.02	 mol/L,	 tris	
buffer	 (pH	 =	 7.4).	 Microsomes	 were	 isolated	 by	 the	 calcium	
aggregation	 method	 [25].	 100	 µL	 of	 liver	 microsomal	
suspension	 (0.5	 mg	 protein)	 was	 incubated	 with	 1	 mmol/L	
each	of	FeSO4	and	ascorbic	acid	with	or	with	out	compounds	in	
a	 total	 volume	 of	 1	mL	 in	 0.1	mol/L	 phosphate	 buffer	 (pH	 =	
7.4).	After	incubation	at	37	oC	for	60	min,	the	reaction	mixture	
was	 boiled	 with	 TBA	 (0.67	 g/	 100	 mL	 water)	 for	 15	 min.	
Formation	of	TBA	reactive	substances	(TBARS)	was	calculated	
from	 the	 absorbance	 at	 535	 nm	 [26].	 BHA	 was	 used	 as	 the	
positive	control.	
	
2.4.4	Statistical	analysis	
	
Tests	 were	 carried	 out	 in	 triplicate	 for	 3‐5	 separate	
experiments.	The	amount	of	compound	needed	to	inhibit	DPPH	
free	 radicals	 and	 Lipid	 peroxyl	 radical	 concentration	 by	 50%,	
IC50,	 was	 graphically	 estimated	 using	 a	 linear	 regression	
algorithm.	
	
3.	Results	and	discussion	
	
3.1.	Chemistry	
	
Indole‐3‐acetic	 acid	 was	 synthesized	 by	 applying	 known	
method	 [27]	 (Scheme	 1).	 The	 active	 site	 for	 the	 coupling	 of	
aniline	and	substituted	anilines	to	the	basic	moiety	was	sparce,	
thus	 we	 carried	 out	 the	 conversion	 of	 acid‐to‐acid	 chloride	
reaction	 in	 order	 to	 obtain	 key	 intermediate	 in	 which,	 the	
coupling	of	aniline	and	substituted	anilines	could	be	done	very	
easily	with	 simple	experiment	protocol	 along	with	good	yield.	
The	synthesis	of	Indole‐3‐acetic	acid	analogues	conjugated	with	
aniline	 and	 substituted	 anilines	 were	 realized	 in	 two	 steps.	
First	 step,	 the	 key	 intermediate	 2(1H‐indole‐3‐yl	 acetyl	
chloride	(2)	was	prepared	 in	good	yield	by	conversion	of	acid	
to	acid	chloride	in	the	presence	of	thionyl	chloride	(Scheme	1).	
In	 the	 second	 step,	 further	 coupling	 of	 respective	 aniline	 and	
substituted	 anilines	 to	 the	 key	 intermediate	 by	 base	
condensation	 reaction	 to	obtain	 the	novel	 Indole‐3‐acetic	acid	
analogues	3‐9	(Scheme	2).	
In	 the	 present	 investigation,	 in	 order	 to	 study	 the	
antioxidant	properties	of	2‐(1H‐	indole‐3‐yl)	acetic	acid	(1)	and	
its	 derivatives	 2‐9,	 we	 have	 synthesized	 array	 of	 Indole‐3‐
acetic	acid	derivatives	conjugated	with	aniline	and	substituted	
anilines.	In	order	to	couple	aniline	and	substituted	anilines,	the	
model	 compound	 2‐(1H‐	 indole‐3‐yl)	 acetic	 acid	 (1)	 is	
converted	 to	 2(1H‐indole‐3‐yl)	 acetyl	 chloride	 (2)	 in	 the	
presence	 of	 thionyl	 chloride.	 Procedure	 for	 synthesis	 is	
outlined	in	Scheme	1.	
2(1H‐indole‐3‐yl)acetyl	chloride	(2)	was	identified	through	
thin	 layer	 chromatography	 technique	 by	 using	 methanol:	
chloroform	(20:80)	as	eluent.	The	excess	 thionyl	chloride	was	
removed	under	high	vaccum.	The	synthesized	compounds	were	
characterized	 by	 various	 physico‐chemical	 and	 spectroscopic	
techniques	 like	 IR,	 1H	 NMR,	 13C	 NMR,	 mass,	 and	 elemental	
analysis.	 IR	 spectrum	 of	 2‐(1H‐indol‐3‐yl)	 acetyl	 chloride	 (2)		
reveals	 the	 presence	 of	 carbonyl	 stretching	 at	 1700	 cm‐1,	
absence	of	‐OH	stretching	at	3739	cm‐1	confirm	the	conversion	
of	 acid	 to	 acid	 chloride.	 The	 structure	 of	 compound	 2	 was	
further	 confirmed	 by	 1H	 NMR	 studies,	 here	 the	 absence	 of	
signal	at	9.7	ppm	which	corresponds	to	carboxylic	‐OH	proton	
confirms	 the	 expected	 acid	 chloride	 product.	 2(1H‐indole‐3‐
yl)acetyl	 chloride	 (2)	 conjugated	with	 aniline	 and	 substituted	
anilines	were	synthesized	and	the	protocol	for	the	synthesis	is	
outlined	in	Scheme	2.	
We	have	carried	out	the	base	condensation	reaction	at	inert	
atmosphere	 (N2)	 with	 good	 yield	 (76‐89%).	 The	 newly	
synthesized	 compounds	 were	 purified	 by	 column	
chromatography	 using	 silica	 gel	 60‐120	 mesh	 and	 ethyl	
acetate:hexane	 (60:40)	 as	 eluent.	 Coupling	 of	 aniline	 and	
substituted	 anilines	 was	 done	 by	 base	 condensation	 reaction	
using	 anhydrous	 K2CO3	 as	 base.	 The	 IR	 spectra	 of	 all	 the	
substituted	aniline	analogues	showed	two	sharp	N‐H	band	i.e.,	
amide	 and	 indole	 (N‐H)	 band	 at	 around	 3198‐3389	 cm‐1	 and	
also	 reveal	 the	 presence	 of	 aromatic	 peaks	 (Ar‐H)	 at	 the	
respective	 region	 2598‐3124	 cm‐1.	 CH2	 stretching	 band	 was	
observed	at	2971‐3026	cm‐1.	1H	NMR	spectra	of	all	conjugated	
analogues	3‐9	 showed	N‐H	protons	 as	 singlet	 at	 4.0‐9.9	ppm.	
The	signal	due	to	phenolic	‐OH	in	all	the	analogues	appeared	as	
singlet	 at	 about	 9.7‐11.2	 ppm.	 In	 addition	 to	 phenolic	 ‐OH,	 ‐
OCH3	protons	present	 in	 the	compound	9	 resonated	as	singlet	
at	3.8	ppm,	other	aromatic	protons	were	observed	at	expected	
regions	 (6.7‐7.9	 ppm).	 All	 the	 analogues	 showed	 mass	
according	to	their	M+	ions.	
	
3.2.	Antioxidant	activities	
	
In	 order	 to	 establish	 some	 structure‐activity	 relationship	
based	on	position	and	presence	of	different	substituents	and	to	
understand	 how	 it	 affects	 the	 antioxidant	 activity,	 present	
research	was	taken.	The	evaluation	of	the	antioxidant	effects	of	
the	 newly	 synthesized	 compounds	 having	 different	
concentrations	were	examined	by	two	well	documented	in	vitro	
assays	like	DPPH	free	radical	scavenging	assay	and	Inhibition	of	
microsomal	lipid	peroxidation	(LPO)	assay.	
Antioxidants	react	with	DPPH,	which	is	a	stable	free	radical	
and	convert	it	to	2,2‐diphenyl‐1‐picryl	hydrazine.	The	degree	of	
discoloration	 indicates	 the	 scavenging	 potentials	 of	 the	
compounds.	 The	 percentage	 (%)	 DPPH	 activities	 of	 all	 the	
newly	synthesized	compounds	were	showed	in	the	Figure	1.	
	
	
Figure	1. %	DPPH	radical	scavenging activity	of	 indole‐3‐acetic	acid	and	
its	analogues.	Each	value	represents	the	mean	±SD	(n=3).	
	
From	the	Figure	1,	compound	1	and	2	showed	considerable	
activities	 and	 this	may	 be	 due	 to	 the	 presence	 of	 indole	 N‐H	
moiety.	 Further	 coupling	 of	 aniline	 and	 substituted	 anilines	
gave	 the	 significant	 changes	 in	 the	 activity.	 Among	 them,	 the	
compound	9	bearing	methoxy	group	(electron	donating	group)	
addition	 to	 phenolic	 moiety	 increased	 the	 stability	 of	 the	
radical	 and	 hence	 the	 antioxidant	 activity	 [23].	 Thus,	 the	
introduction	 of	 a	 methoxy	 group	 increases	 the	 hydrogen	
donation	ability	and	therefore	showed	dominant	DPPH	activity	
compare	 to	 BHA	 an	 internal	 standard.	 All	 the	 analogues	
demonstrated	 significant	 radical	 scavenging	 effect	 in	
concentration	dependent	manner.	On	 the	 other	hand,	 the	half	
inhibition	 concentration	 (IC50)	 for	 all	 the	 newly	 synthesized	
analogues	 including	 the	 reference	 antioxidant	 BHA	 was	
calculated	 graphically	 using	 a	 linear	 regression	 algorithm	and	
shown	in	Table	1.	
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The	presence	of	nitro	group	(electron	with	drawing	group)	
in	 compound	 7	 exhibits	 slightly	 less	 activity	 to	 that	 of	 9.	
Compounds	4‐6	 showed	 comparable,	 but	 slightly	 less	 activity	
to	the	standard	BHA.	The	increasing	order	of	DPPH	activity	of	
newly	synthesized	analogues	is	as	follows	9	>	BHA	>	6	>	7	>	4	>	
5	>	8	>	3	>	1	>2.	
From	 LPO	 studies,	 as	 shown	 in	 Figure	 2,	 among	 the	
synthesized	compounds	1,	2,	 and	3	 inhibits	 lipid	peroxidation	
moderately	 and	 showed	 considerable	 activities.	 Compound	4,	
5,	6,	7	and	8	and	inhibits	fairly	the	peroxyl	radicals	generated	
in	 the	 system	 showed	 good	 activities.	 Whereas,	 compound	 9	
bearing	methoxy	group	(electron	donating	group)	additions	to	
phenolic	 moiety	 demonstrate	 dominant	 on	 inhibiting	 LPO	 of	
liver	microsomes.	
	
	
	
Figure	2.		%	Inhibition	of	microsomal	LPO	by	indole‐3‐acetic	acid	and	newly	
synthesized	analogues.	Each	value	represents	the	mean	±SD	(n=3).
	
IC50	 values	 of	 LPO	 inhibition	 for	 the	 newly	 synthesized	
analogues	 were	 depicted	 in	 Table	 1.	 LPO	 has	 been	 broadly	
defined	as	the	oxidative	deterioration	of	polyunsaturated	lipids	
[28].	 Initiation	 of	 a	 peroxidation	 sequence	 in	 a	membrane	 or	
polyunsaturated	 fatty	acid	 is	due	 to	abstraction	of	a	hydrogen	
atom	 from	 the	 double	 bond	 in	 the	 fatty	 acid.	 The	 free	 radical	
tends	 to	 stabilize	 by	 a	molecular	 rearrangement	 to	produce	 a	
conjugated	 diene,	 which	 then	 readily	 reacts	 with	 oxygen	
molecule	 to	 give	 a	 peroxy	 radical	 [29].	 Peroxy	 radicals	 can	
abstract	a	hydrogen	atom	from	another	molecule	 to	give	 lipid	
hydroperoxide,	 R‐OOH.	 A	 probable	 alternative	 fate	 of	 peroxy	
radicals	is	to	form	cyclic	endoperoxides	fragment	to	aldehydes	
such	as	malondialdehyde	(MDA)	and	polymerization	products.	
MDA	 and	 4‐hydroxy	 nonenal	 are	 the	 major	 break	 down	
products	of	LPO.	MDA	is	usually	taken	as	a	marker	of	LPO	and	
oxidative	 stress	 [30].	 All	 the	 synthesized	 compounds	 exhibit	
same	order	of	activity	in	both	the	assay	performed.	
	
Table	1.	50%	Inhibition	of	DPPH	radical	and	Microsomal	LPO	inhibition	by	
indole‐3‐acetic	acid	and	its	analogues	each	value	represents	mean	±	SD	(n=3)	
Compounds	 DPPH	activity	IC50	
(µM/mL)	
Microsomal	LPO	inhibition	IC50	
(µM/mL)	
1	 	75±0.1	 	80±0.7	
2	 	79±0.3	 	85±0.4	
3	 	72±0.7	 	70±0.3	
4	 	18±0.9	 	16±0.8	
5	 	19±0.5	 	18±0.1	
6	 	14±0.3	 	12±0.3	
7	 	17±0.1	 	14±0.5	
8	 	21±0.8	 	20±0.9	
9	 	10±0.5	 	7±0.1	
BHA	 	12±0.7	 	10±0.1	
	
4.	Conclusion	
	
Synthesis	and	antioxidant	properties	of	indole‐3‐acetic	acid	
and	its	derivatives	have	been	investigated.	Indole‐3‐acetic	acid	
conjugated	with	aniline	and	substituted	anilines	were	prepared	
by	base	condensation	reaction	in	moderate	to	high	yield.	A	key	
intermediate,	 2‐(1H‐indol‐3‐yl)acetyl	 chloride	 (2)	 was	
prepared	by	conversion	of	indole‐3‐acetic	acid	to	acid	chloride.	
The	antioxidant	properties	of	new	analogues	were	evaluated	by	
DPPH	free	radical	scavenging	activity	and	LPO	inhibition	assay.	
In	both	the	assays,	initially	2‐(1H‐indol‐3‐yl)acetyl	chloride	(2)	
showed	 considerable	 activity.	 Further	 coupling	 of	 aniline	 and	
substituted	 anilines	 to	 2‐(1H‐indol‐3‐yl)acetyl	 chloride	 (3‐9)	
enhance	 the	 antioxidant	 properties.	 Coupling	 of	 methoxy	
substituted	 i.e	 compound	9	 revealed	 high	 antioxidant	 activity	
which	 was	 more	 than	 the	 standard	 (BHA).	 It	 is	 conceivable	
from	these	studies	that	the	coupling	of	aniline	and	substituted	
anilines	 is	 the	 most	 important	 feature	 for	 the	 significant	
antioxidant	 activity	 of	 indole‐3‐acetic	 acid	 analogues	 studied.	
Our	 investigation	 may	 be	 use	 full	 in	 the	 treatment	 of	
pathologies	in	which	free	radical	oxidation	plays	a	fundamental	
role.	
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